4th AI4Lungs Stakeholder Forum Meeting: Navigating Ethical, Legal & Social Impacts of AI in Healthcare

On 13 November, the AI4Lungs consortium hosted the 4th Stakeholder Forum meeting, bringing together project partners and external experts for a focused discussion on the ethical, legal, and social implications (ELSI) of developing cutting-edge AI tools for respiratory disease diagnosis and patient stratification.

The session, co-hosted by Deloitte and Timelex, offered a deep dive into the frameworks that will guide responsible innovation throughout the AI4Lungs project.

Understanding Digital Ethics and Legal Perspectives in AI4LUNGS project

The meeting opened with Deloitte presenting an overview of the Digital Ethics Risk Assessment (DERA), which is the methodology used in AI4LUNGS to assess and mitigate ethical risks linked to AI development. The DERA framework provides a structured way to evaluate issues such as:

• fairness and bias in AI models,

• transparency and explainability,

• data quality and integrity,

• accountability in clinical decision support systems.

This foundation ensures that ethical considerations remain integrated into the project’s technical and clinical activities.

Next, our legal experts from Timelex outlined the regulatory landscape governing AI4Lungs, emphasising two core regulations: the GDPR (General Data Protection Regulation), and the EU AI Act.

Discussion: Human-Centric AI and the Role of Clinicians

The meeting concluded with an interactive discussion in which stakeholders raised concerns about over-reliance on AI in clinical settings. Participants emphasised the importance of interdisciplinary collaboration and highlighted the need to support clinicians in adopting AI tools while preserving critical thinking and a human-centred approach.

The 4th Stakeholder Forum meeting highlighted a shared commitment to ensuring that AI4Lungs develops safe, ethical, and responsible AI solutions for respiratory healthcare. As the project progresses, the consortium will continue refining the ELSI and regulatory frameworks, integrating stakeholder feedback, and ensuring that patient well-being and clinician support remain at the heart of every innovation.

---

Stay updated on the AI4LUNGS research development and progress by following the project on X and LinkedIn, and subscribing to our newsletter for the latest insights and advancements.